Muscle (basic/M-type) isozyme of adenylosuccinate synthetase (AMPSase 1; synonym ADSSL1; EC 6.3.4.4), a cytosolic homodimeric enzyme predominantly expressed in skeletal muscle and heart. It catalyzes the first, committed step of the IMP-to-AMP branch of purine metabolism, the Mg2+-dependent, GTP-driven condensation of IMP with L-aspartate to form N6-(1,2-dicarboxyethyl)-AMP (adenylosuccinate/S-AMP), GDP and phosphate; adenylosuccinate lyase (ADSL) then cleaves S-AMP to AMP and fumarate. Together with ADSL, ADSS1 also runs the AMP-regenerating limb of the muscle purine nucleotide cycle, which interconverts IMP and AMP and contributes to muscle energetics (glycolysis) and ammoniagenesis. The paralog ADSS2 is the liver/ubiquitous (acidic) isozyme. Biallelic loss-of-function variants in ADSS1 cause adenylosuccinate synthetase 1 (ADSSL1)-related distal myopathy (MPD5), an autosomal recessive adolescent/adult-onset distal myopathy.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004019
adenylosuccinate synthase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred adenylosuccinate synthase activity, the defining molecular function of ADSS1 and the entire adenylosuccinate synthetase family. This is directly confirmed experimentally for the human protein.
Reason: This is the core, well-supported molecular function. The IBA is grounded in a broad set of orthologs (E. coli purA, yeast, mouse muscle/non-muscle isozymes) and is confirmed for the human enzyme by direct assay (PMID:15786719) and by a mutation study (PMID:26506222).
Supporting Evidence:
PMID:15786719
Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred cytoplasmic localization, consistent with the experimentally observed cytoplasmic localization of the human protein.
Reason: Adenylosuccinate synthetase is a soluble cytosolic enzyme across the family; the human protein was directly observed in the cytoplasm when overexpressed (PMID:15786719). Cytosol (GO:0005829) is the more precise term captured elsewhere.
Supporting Evidence:
PMID:15786719
Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
|
|
GO:0044208
'de novo' AMP biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred role in de novo AMP biosynthesis. ADSS1 catalyzes step 1 of 2 of the conversion of IMP to AMP, the first committed step of the de novo AMP branch of purine metabolism.
Reason: This is a core biological process for the gene, matching the UniProt-annotated pathway (AMP biosynthesis via the de novo pathway, AMP from IMP, step 1 of 2). Well supported by orthology and by the enzyme's characterized reaction.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP
|
|
GO:0046040
IMP metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred involvement in IMP metabolism. IMP is the direct substrate of adenylosuccinate synthase, consumed in the first committed step of AMP synthesis.
Reason: Accurate; ADSS1 consumes IMP (with GTP and aspartate) and, as part of the purine nucleotide cycle, contributes to IMP/AMP interconversion. Broader than the specific catalytic function but a correct process annotation.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
|
|
GO:0000166
nucleotide binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based inference of nucleotide binding. ADSS1 binds GTP (and its product GDP) and IMP as substrates; nucleotide binding is a general parent of these specific activities.
Reason: Correct but general. The enzyme has a P-loop NTPase fold and documented GTP/IMP binding sites (UniProt BINDING features). More specific GTP binding (GO:0005525) is also annotated. Retained as an accurate, if broad, molecular-function annotation.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Nucleotide-binding
|
|
GO:0000287
magnesium ion binding
|
IEA
GO_REF:0000104 |
ACCEPT |
Summary: Rule-based inference of magnesium ion binding. Adenylosuccinate synthase is a Mg2+-dependent enzyme that binds one Mg2+ ion per subunit, coordinating the GTP/phosphoryl-transfer chemistry.
Reason: Supported by UniProt cofactor and binding-site annotations (Mg2+ bound at residues 43 and 70), consistent with the conserved catalytic mechanism of the family.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Binds 1 Mg(2+) ion per subunit.
|
|
GO:0004019
adenylosuccinate synthase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (ARBA/UniRule/InterPro/RHEA/EC) inference of the core adenylosuccinate synthase activity, duplicating the experimentally and phylogenetically supported molecular function.
Reason: Correct core molecular function (EC 6.3.4.4; RHEA 15753), consistent with the IDA, IMP, and IBA annotations for the same term.
Supporting Evidence:
PMID:15786719
Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
|
|
GO:0005525
GTP binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated inference of GTP binding. GTP is a required co-substrate of the adenylosuccinate synthase reaction, providing the energy for the ligation and being converted to GDP + phosphate.
Reason: Well supported; UniProt documents multiple GTP-binding regions (residues 42-48, 70-72, 337, 363-365, 445-448) and the reaction consumes GTP. Also independently annotated NAS from PMID:15786719.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
N(6)-(1,2-dicarboxyethyl)-AMP + GDP
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated inference of cytoplasmic localization, matching the experimental cytoplasmic localization and the cytosol annotation.
Reason: Consistent with UniProt subcellular location (Cytoplasm) and the direct experimental observation in PMID:15786719.
Supporting Evidence:
PMID:15786719
Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
|
|
GO:0006164
purine nucleotide biosynthetic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based inference of involvement in purine nucleotide biosynthesis. ADSS1 acts in the IMP-to-AMP branch, producing the purine nucleotide AMP.
Reason: Correct but general parent of the more specific AMP biosynthesis terms; retained as an accurate process annotation.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
|
|
GO:0006167
AMP biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated inference of involvement in AMP biosynthesis, the direct downstream product process of the adenylosuccinate synthase reaction (via ADSL cleavage of S-AMP to AMP). Also independently supported by IDA (PMID:15786719).
Reason: Core biological process; the enzyme catalyzes the committed step producing the AMP precursor adenylosuccinate.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
|
|
GO:0044208
'de novo' AMP biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (UniRule/UniPathway) inference of the de novo AMP biosynthetic process, matching the IBA annotation and the UniProt pathway assignment.
Reason: Correct and specific core process (de novo AMP-from-IMP pathway, step 1 of 2).
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
AMP biosynthesis via de novo pathway
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520, the paralog ADSS2). "Protein binding" is uninformative as a molecular function.
Reason: The bare GO:0005515 term conveys no specific function. The recorded partner is the paralog ADSS2, consistent with the UniProt-documented ADSS1-ADSS2 interaction, but this is a large-scale interactome dataset that does not establish a discrete functional MF for ADSS1. Per curation policy, retained (not removed) but flagged as over-annotation; the informative function is captured by GO:0004019.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Q8N142; P30520: ADSS2; NbExp=4
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520, the paralog ADSS2). Uninformative bare protein-binding term.
Reason: As above, a high-throughput interactome mapping to the paralog ADSS2. Retained per policy but flagged as over-annotation; adds no specific molecular function beyond the adenylosuccinate synthase activity.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Q8N142; P30520: ADSS2; NbExp=4
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520, the paralog ADSS2). Uninformative bare protein-binding term.
Reason: As above, a multimodal cell-map / interactome dataset mapping to ADSS2. Retained per policy but flagged as over-annotation.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
Q8N142; P30520: ADSS2; NbExp=4
|
|
GO:0044209
AMP salvage
|
IEA
GO_REF:0000107 |
MARK AS OVER ANNOTATED |
Summary: Ensembl-orthology inference of involvement in AMP salvage. ADSS1 in muscle operates the AMP-regenerating limb of the purine nucleotide cycle (IMP to AMP), which recycles the purine nucleotide pool.
Reason: The primary and precise characterization of ADSS1 is de novo AMP biosynthesis (AMP from IMP, step 1 of 2). AMP salvage (reuse of preformed adenine/adenosine) is not the enzyme's committed-step chemistry; the overlap is via the purine nucleotide cycle that regenerates AMP from IMP. Kept as it is not strictly wrong, but flagged as a less precise, orthology-transferred process; GO:0044208 is the accurate term.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
which interconverts IMP and AMP to regulate the nucleotide levels
|
|
GO:0004019
adenylosuccinate synthase activity
|
IMP
PMID:26506222 ADSSL1 mutation relevant to autosomal recessive adolescent o... |
ACCEPT |
Summary: Adenylosuccinate synthase activity inferred from mutant phenotype; disease variants in ADSSL1 reduce catalytic activity, confirming that the wild-type protein provides this function.
Reason: Direct genetic/functional evidence. Both MPD5 mutations (p.D304N and p.I350fs) decreased enzymatic activity, and the D261N variant characterized in UniProt shows decreased adenylosuccinate synthase activity, tying the human gene product's core catalytic function to disease.
Supporting Evidence:
PMID:26506222
Both the D304N and I350fs mutations in ADSSL1 led to decreased enzymatic activity.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-111524 |
ACCEPT |
Summary: Cytosolic localization asserted by Reactome for the adenylosuccinate synthase reaction, consistent with the soluble cytosolic nature of the enzyme.
Reason: Cytosol is the precise cellular component for this soluble enzyme, agreeing with the experimental cytoplasm localization (PMID:15786719) and UniProt subcellular location. This is the preferred specific location term.
Supporting Evidence:
Reactome:R-HSA-111524
Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and orthophosphate
|
|
GO:0002376
immune system process
|
NAS
PMID:15786719 Molecular cloning and characterization of a novel muscle ade... |
KEEP AS NON CORE |
Summary: Non-traceable author statement based on the observation that AdSSL1 is expressed in hematopoietic/leukemia cell lines in a stimulation-dependent manner. This is an expression correlation, not an established immune function.
Reason: ADSS1 is fundamentally a purine-metabolism enzyme predominantly expressed in muscle; the immune-system link rests only on expression in leukemia cells after stimulation, with no demonstrated mechanistic immune role. Kept as a non-core, weakly-supported process rather than a core function.
Supporting Evidence:
PMID:15786719
After stimulation, leukemia cells express AdSSL1 in a time-dependent manner
|
|
GO:0004019
adenylosuccinate synthase activity
|
IDA
PMID:15786719 Molecular cloning and characterization of a novel muscle ade... |
ACCEPT |
Summary: Direct assay of recombinant human AdSSL1 demonstrating adenylosuccinate synthase activity (adenylosuccinate formation). This is the primary experimental evidence for the core molecular function.
Reason: Strong direct experimental support for the defining catalytic activity of the gene product.
Supporting Evidence:
PMID:15786719
Recombinant AdSSL1 protein possesses typical enzymatic activity to catalyze adenylosuccinate formation.
|
|
GO:0005525
GTP binding
|
NAS
PMID:15786719 Molecular cloning and characterization of a novel muscle ade... |
ACCEPT |
Summary: Author statement of GTP binding, reflecting the conserved GTP-dependent mechanism of adenylosuccinate synthetase; GTP is a co-substrate of the reaction.
Reason: Consistent with the well-characterized GTP-dependent catalytic mechanism and the multiple GTP-binding regions annotated in UniProt; also independently supported by IEA.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
N(6)-(1,2-dicarboxyethyl)-AMP + GDP
|
|
GO:0005737
cytoplasm
|
IDA
PMID:15786719 Molecular cloning and characterization of a novel muscle ade... |
ACCEPT |
Summary: Direct experimental observation that overexpressed AdSSL1 localizes to the cytoplasm in COS-7 cells.
Reason: Direct localization evidence for the human protein; cytosol (GO:0005829) is the more granular equivalent captured from Reactome.
Supporting Evidence:
PMID:15786719
Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
|
|
GO:0006167
AMP biosynthetic process
|
IDA
PMID:15786719 Molecular cloning and characterization of a novel muscle ade... |
ACCEPT |
Summary: Direct evidence linking ADSS1 to AMP biosynthesis via its characterized adenylosuccinate-forming activity, the committed step in AMP synthesis.
Reason: Core biological process, directly supported by the enzyme assay and the description of AdSSL1 as catalyzing the first committed step in AMP synthesis.
Supporting Evidence:
PMID:15786719
which catalyzes the first committed step in AMP synthesis
|
|
GO:0042301
phosphate ion binding
|
NAS
PMID:15786719 Molecular cloning and characterization of a novel muscle ade... |
MARK AS OVER ANNOTATED |
Summary: Author statement of phosphate ion binding. Phosphate is a reaction product and the enzyme binds the phosphate groups of its GTP/GDP and IMP ligands, but a standalone phosphate-ion-binding molecular function is not informative for this enzyme.
Reason: The enzyme's phosphate handling is part of GTP binding and the ligase catalytic mechanism (phosphate is released as a product). A discrete phosphate-ion-binding MF annotation adds little and risks over-representing an incidental feature; the informative functions are GO:0004019 and GO:0005525. Kept (not wrong) but flagged.
Supporting Evidence:
file:human/ADSS1/ADSS1-uniprot.txt
N(6)-(1,2-dicarboxyethyl)-AMP + GDP + phosphate
|
Q: Does ADSS1 have non-catalytic or muscle-specific regulatory roles beyond the purine nucleotide cycle that explain the tissue-restricted, distal-predominant myopathy phenotype, given the ubiquitously expressed paralog ADSS2?
Q: Is the observed expression of AdSSL1 in stimulated leukemia/hematopoietic cells associated with any genuine immune function, or purely a metabolic response?
Experiment: Steady-state kinetic characterization of purified recombinant human ADSS1 (Km for IMP, L-aspartate, GTP; Mg2+ dependence) compared with ADSS2, to quantify the muscle isozyme's catalytic properties.
Hypothesis: The muscle isozyme ADSS1 has kinetic properties distinct from ADSS2 that suit the high purine-nucleotide-cycle flux of skeletal muscle.
Experiment: Muscle-specific Adss1 knockout or knock-in of the MPD5 D304N variant in mouse to test whether purine nucleotide cycle disruption drives the distal myopathy phenotype.
Hypothesis: Loss of ADSS1 catalytic activity impairs the muscle purine nucleotide cycle, causing the distal myopathy seen in MPD5 patients.
Deep research: falcon provider is out of credits (HTTP 402); no -deep-research-falcon.md
was generated. Review grounded in the cached UniProt record, the seeded GOA, and cached
publications/PMID_*.md. No content was fabricated as deep research.
protein binding IPIs -> MARK_AS_OVER_ANNOTATEDid: Q8N142
gene_symbol: ADSS1
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: Muscle (basic/M-type) isozyme of adenylosuccinate synthetase (AMPSase 1;
synonym ADSSL1; EC 6.3.4.4), a cytosolic homodimeric enzyme predominantly expressed
in skeletal muscle and heart. It catalyzes the first, committed step of the IMP-to-AMP
branch of purine metabolism, the Mg2+-dependent, GTP-driven condensation of IMP with
L-aspartate to form N6-(1,2-dicarboxyethyl)-AMP (adenylosuccinate/S-AMP), GDP and phosphate;
adenylosuccinate lyase (ADSL) then cleaves S-AMP to AMP and fumarate. Together with ADSL,
ADSS1 also runs the AMP-regenerating limb of the muscle purine nucleotide cycle, which
interconverts IMP and AMP and contributes to muscle energetics (glycolysis) and
ammoniagenesis. The paralog ADSS2 is the liver/ubiquitous (acidic) isozyme. Biallelic
loss-of-function variants in ADSS1 cause adenylosuccinate synthetase 1 (ADSSL1)-related
distal myopathy (MPD5), an autosomal recessive adolescent/adult-onset distal myopathy.
alternative_products:
- name: '1'
id: Q8N142-1
- name: '2'
id: Q8N142-2
sequence_note: VSP_008421
existing_annotations:
- term:
id: GO:0004019
label: adenylosuccinate synthase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Phylogenetically inferred adenylosuccinate synthase activity, the defining
molecular function of ADSS1 and the entire adenylosuccinate synthetase family.
This is directly confirmed experimentally for the human protein.
action: ACCEPT
reason: This is the core, well-supported molecular function. The IBA is grounded in a
broad set of orthologs (E. coli purA, yeast, mouse muscle/non-muscle isozymes) and is
confirmed for the human enzyme by direct assay (PMID:15786719) and by a mutation study
(PMID:26506222).
supported_by:
- reference_id: PMID:15786719
supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
catalyze adenylosuccinate formation.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: Phylogenetically inferred cytoplasmic localization, consistent with the
experimentally observed cytoplasmic localization of the human protein.
action: ACCEPT
reason: Adenylosuccinate synthetase is a soluble cytosolic enzyme across the family;
the human protein was directly observed in the cytoplasm when overexpressed
(PMID:15786719). Cytosol (GO:0005829) is the more precise term captured elsewhere.
supported_by:
- reference_id: PMID:15786719
supporting_text: Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
- term:
id: GO:0044208
label: "'de novo' AMP biosynthetic process"
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetically inferred role in de novo AMP biosynthesis. ADSS1 catalyzes
step 1 of 2 of the conversion of IMP to AMP, the first committed step of the de novo
AMP branch of purine metabolism.
action: ACCEPT
reason: This is a core biological process for the gene, matching the UniProt-annotated
pathway (AMP biosynthesis via the de novo pathway, AMP from IMP, step 1 of 2). Well
supported by orthology and by the enzyme's characterized reaction.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: Purine metabolism; AMP biosynthesis via de novo pathway; AMP
from IMP
- term:
id: GO:0046040
label: IMP metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetically inferred involvement in IMP metabolism. IMP is the direct
substrate of adenylosuccinate synthase, consumed in the first committed step of
AMP synthesis.
action: ACCEPT
reason: Accurate; ADSS1 consumes IMP (with GTP and aspartate) and, as part of the
purine nucleotide cycle, contributes to IMP/AMP interconversion. Broader than the
specific catalytic function but a correct process annotation.
supported_by:
- reference_id: PMID:15786719
supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
id: GO:0000166
label: nucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: InterPro-based inference of nucleotide binding. ADSS1 binds GTP (and its
product GDP) and IMP as substrates; nucleotide binding is a general parent of these
specific activities.
action: ACCEPT
reason: Correct but general. The enzyme has a P-loop NTPase fold and documented GTP/IMP
binding sites (UniProt BINDING features). More specific GTP binding (GO:0005525) is
also annotated. Retained as an accurate, if broad, molecular-function annotation.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: Nucleotide-binding
- term:
id: GO:0000287
label: magnesium ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000104
qualifier: enables
review:
summary: Rule-based inference of magnesium ion binding. Adenylosuccinate synthase is
a Mg2+-dependent enzyme that binds one Mg2+ ion per subunit, coordinating the
GTP/phosphoryl-transfer chemistry.
action: ACCEPT
reason: Supported by UniProt cofactor and binding-site annotations (Mg2+ bound at
residues 43 and 70), consistent with the conserved catalytic mechanism of the family.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: Binds 1 Mg(2+) ion per subunit.
- term:
id: GO:0004019
label: adenylosuccinate synthase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Automated (ARBA/UniRule/InterPro/RHEA/EC) inference of the core adenylosuccinate
synthase activity, duplicating the experimentally and phylogenetically supported
molecular function.
action: ACCEPT
reason: Correct core molecular function (EC 6.3.4.4; RHEA 15753), consistent with the
IDA, IMP, and IBA annotations for the same term.
supported_by:
- reference_id: PMID:15786719
supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
catalyze adenylosuccinate formation.
- term:
id: GO:0005525
label: GTP binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Automated inference of GTP binding. GTP is a required co-substrate of the
adenylosuccinate synthase reaction, providing the energy for the ligation and being
converted to GDP + phosphate.
action: ACCEPT
reason: Well supported; UniProt documents multiple GTP-binding regions (residues 42-48,
70-72, 337, 363-365, 445-448) and the reaction consumes GTP. Also independently
annotated NAS from PMID:15786719.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: Automated inference of cytoplasmic localization, matching the experimental
cytoplasmic localization and the cytosol annotation.
action: ACCEPT
reason: Consistent with UniProt subcellular location (Cytoplasm) and the direct
experimental observation in PMID:15786719.
supported_by:
- reference_id: PMID:15786719
supporting_text: Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
- term:
id: GO:0006164
label: purine nucleotide biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: InterPro-based inference of involvement in purine nucleotide biosynthesis.
ADSS1 acts in the IMP-to-AMP branch, producing the purine nucleotide AMP.
action: ACCEPT
reason: Correct but general parent of the more specific AMP biosynthesis terms; retained
as an accurate process annotation.
supported_by:
- reference_id: PMID:15786719
supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
id: GO:0006167
label: AMP biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Automated inference of involvement in AMP biosynthesis, the direct downstream
product process of the adenylosuccinate synthase reaction (via ADSL cleavage of S-AMP
to AMP). Also independently supported by IDA (PMID:15786719).
action: ACCEPT
reason: Core biological process; the enzyme catalyzes the committed step producing the
AMP precursor adenylosuccinate.
supported_by:
- reference_id: PMID:15786719
supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
id: GO:0044208
label: "'de novo' AMP biosynthetic process"
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Automated (UniRule/UniPathway) inference of the de novo AMP biosynthetic
process, matching the IBA annotation and the UniProt pathway assignment.
action: ACCEPT
reason: Correct and specific core process (de novo AMP-from-IMP pathway, step 1 of 2).
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: AMP biosynthesis via de novo pathway
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520,
the paralog ADSS2). "Protein binding" is uninformative as a molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: The bare GO:0005515 term conveys no specific function. The recorded partner is
the paralog ADSS2, consistent with the UniProt-documented ADSS1-ADSS2 interaction, but
this is a large-scale interactome dataset that does not establish a discrete functional
MF for ADSS1. Per curation policy, retained (not removed) but flagged as
over-annotation; the informative function is captured by GO:0004019.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: "Q8N142; P30520: ADSS2; NbExp=4"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520,
the paralog ADSS2). Uninformative bare protein-binding term.
action: MARK_AS_OVER_ANNOTATED
reason: As above, a high-throughput interactome mapping to the paralog ADSS2. Retained
per policy but flagged as over-annotation; adds no specific molecular function beyond
the adenylosuccinate synthase activity.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: "Q8N142; P30520: ADSS2; NbExp=4"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
qualifier: enables
review:
summary: IntAct proteome-scale interaction annotation (WITH/FROM UniProtKB:P30520,
the paralog ADSS2). Uninformative bare protein-binding term.
action: MARK_AS_OVER_ANNOTATED
reason: As above, a multimodal cell-map / interactome dataset mapping to ADSS2. Retained
per policy but flagged as over-annotation.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: "Q8N142; P30520: ADSS2; NbExp=4"
- term:
id: GO:0044209
label: AMP salvage
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Ensembl-orthology inference of involvement in AMP salvage. ADSS1 in muscle
operates the AMP-regenerating limb of the purine nucleotide cycle (IMP to AMP), which
recycles the purine nucleotide pool.
action: MARK_AS_OVER_ANNOTATED
reason: The primary and precise characterization of ADSS1 is de novo AMP biosynthesis
(AMP from IMP, step 1 of 2). AMP salvage (reuse of preformed adenine/adenosine) is not
the enzyme's committed-step chemistry; the overlap is via the purine nucleotide cycle
that regenerates AMP from IMP. Kept as it is not strictly wrong, but flagged as a less
precise, orthology-transferred process; GO:0044208 is the accurate term.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: which interconverts IMP and AMP to regulate the nucleotide levels
- term:
id: GO:0004019
label: adenylosuccinate synthase activity
evidence_type: IMP
original_reference_id: PMID:26506222
qualifier: enables
review:
summary: Adenylosuccinate synthase activity inferred from mutant phenotype; disease
variants in ADSSL1 reduce catalytic activity, confirming that the wild-type protein
provides this function.
action: ACCEPT
reason: Direct genetic/functional evidence. Both MPD5 mutations (p.D304N and p.I350fs)
decreased enzymatic activity, and the D261N variant characterized in UniProt shows
decreased adenylosuccinate synthase activity, tying the human gene product's core
catalytic function to disease.
supported_by:
- reference_id: PMID:26506222
supporting_text: Both the D304N and I350fs mutations in ADSSL1 led to decreased
enzymatic activity.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-111524
qualifier: located_in
review:
summary: Cytosolic localization asserted by Reactome for the adenylosuccinate synthase
reaction, consistent with the soluble cytosolic nature of the enzyme.
action: ACCEPT
reason: Cytosol is the precise cellular component for this soluble enzyme, agreeing with
the experimental cytoplasm localization (PMID:15786719) and UniProt subcellular
location. This is the preferred specific location term.
supported_by:
- reference_id: Reactome:R-HSA-111524
supporting_text: Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze
the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and
orthophosphate
- term:
id: GO:0002376
label: immune system process
evidence_type: NAS
original_reference_id: PMID:15786719
qualifier: involved_in
review:
summary: Non-traceable author statement based on the observation that AdSSL1 is
expressed in hematopoietic/leukemia cell lines in a stimulation-dependent manner.
This is an expression correlation, not an established immune function.
action: KEEP_AS_NON_CORE
reason: ADSS1 is fundamentally a purine-metabolism enzyme predominantly expressed in
muscle; the immune-system link rests only on expression in leukemia cells after
stimulation, with no demonstrated mechanistic immune role. Kept as a non-core,
weakly-supported process rather than a core function.
supported_by:
- reference_id: PMID:15786719
supporting_text: After stimulation, leukemia cells express AdSSL1 in a time-dependent
manner
- term:
id: GO:0004019
label: adenylosuccinate synthase activity
evidence_type: IDA
original_reference_id: PMID:15786719
qualifier: enables
review:
summary: Direct assay of recombinant human AdSSL1 demonstrating adenylosuccinate
synthase activity (adenylosuccinate formation). This is the primary experimental
evidence for the core molecular function.
action: ACCEPT
reason: Strong direct experimental support for the defining catalytic activity of the
gene product.
supported_by:
- reference_id: PMID:15786719
supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
catalyze adenylosuccinate formation.
- term:
id: GO:0005525
label: GTP binding
evidence_type: NAS
original_reference_id: PMID:15786719
qualifier: enables
review:
summary: Author statement of GTP binding, reflecting the conserved GTP-dependent
mechanism of adenylosuccinate synthetase; GTP is a co-substrate of the reaction.
action: ACCEPT
reason: Consistent with the well-characterized GTP-dependent catalytic mechanism and
the multiple GTP-binding regions annotated in UniProt; also independently supported by
IEA.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:15786719
qualifier: located_in
review:
summary: Direct experimental observation that overexpressed AdSSL1 localizes to the
cytoplasm in COS-7 cells.
action: ACCEPT
reason: Direct localization evidence for the human protein; cytosol (GO:0005829) is the
more granular equivalent captured from Reactome.
supported_by:
- reference_id: PMID:15786719
supporting_text: Overexpressed AdSSL1 protein in COS-7 cells locates in cytoplasm.
- term:
id: GO:0006167
label: AMP biosynthetic process
evidence_type: IDA
original_reference_id: PMID:15786719
qualifier: involved_in
review:
summary: Direct evidence linking ADSS1 to AMP biosynthesis via its characterized
adenylosuccinate-forming activity, the committed step in AMP synthesis.
action: ACCEPT
reason: Core biological process, directly supported by the enzyme assay and the
description of AdSSL1 as catalyzing the first committed step in AMP synthesis.
supported_by:
- reference_id: PMID:15786719
supporting_text: which catalyzes the first committed step in AMP synthesis
- term:
id: GO:0042301
label: phosphate ion binding
evidence_type: NAS
original_reference_id: PMID:15786719
qualifier: enables
review:
summary: Author statement of phosphate ion binding. Phosphate is a reaction product
and the enzyme binds the phosphate groups of its GTP/GDP and IMP ligands, but a
standalone phosphate-ion-binding molecular function is not informative for this
enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: The enzyme's phosphate handling is part of GTP binding and the ligase catalytic
mechanism (phosphate is released as a product). A discrete phosphate-ion-binding MF
annotation adds little and risks over-representing an incidental feature; the
informative functions are GO:0004019 and GO:0005525. Kept (not wrong) but flagged.
supported_by:
- reference_id: file:human/ADSS1/ADSS1-uniprot.txt
supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
+ phosphate
core_functions:
- description: Catalyzes the first committed step of AMP biosynthesis from IMP - the
Mg2+-dependent, GTP-driven condensation of IMP with L-aspartate to yield
adenylosuccinate (N6-(1,2-dicarboxyethyl)-AMP), GDP and phosphate (EC 6.3.4.4) - as the
muscle isozyme of adenylosuccinate synthetase.
molecular_function:
id: GO:0004019
label: adenylosuccinate synthase activity
directly_involved_in:
- id: GO:0044208
label: "'de novo' AMP biosynthetic process"
- id: GO:0006167
label: AMP biosynthetic process
supported_by:
- reference_id: PMID:15786719
supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
catalyze adenylosuccinate formation.
- reference_id: PMID:26506222
supporting_text: Both the D304N and I350fs mutations in ADSSL1 led to decreased
enzymatic activity.
locations:
- id: GO:0005829
label: cytosol
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000104
title: Electronic Gene Ontology annotations created by transferring manual GO annotations
between related proteins based on shared sequence features
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:15786719
title: Molecular cloning and characterization of a novel muscle adenylosuccinate
synthetase, AdSSL1, from human bone marrow stromal cells.
findings:
- statement: Human AdSSL1 is the muscle isozyme of adenylosuccinate synthetase that
catalyzes the first committed step in AMP synthesis; recombinant protein has typical
adenylosuccinate synthase activity and the protein localizes to the cytoplasm.
supporting_text: Recombinant AdSSL1 protein possesses typical enzymatic activity to
catalyze adenylosuccinate formation.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: PubMed-verified; primary characterization of human ADSS1/AdSSL1
(activity, cytoplasmic localization, muscle-predominant expression). Abstract-only in
cache but the abstract directly supports the enzymatic and localization annotations.
- id: PMID:26506222
title: ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy.
findings:
- statement: Biallelic ADSSL1 mutations cause autosomal recessive adolescent-onset distal
myopathy (MPD5); the mutations decrease adenylosuccinate synthase enzymatic activity.
supporting_text: Both the D304N and I350fs mutations in ADSSL1 led to decreased
enzymatic activity.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: PubMed-verified; establishes the disease link (MPD5) and provides
mutant-phenotype (IMP) evidence for the catalytic function. Abstract-only in cache;
the abstract supports the activity and disease claims.
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Proteome-scale interactome study; source of an IntAct IPI protein-binding
annotation (partner ADSS2). Does not establish a specific molecular function for ADSS1.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Proteome-scale interactome study; source of an IntAct IPI protein-binding
annotation (partner ADSS2). Uninformative bare protein-binding evidence for ADSS1.
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Multimodal cell-map / interactome study; source of an IntAct IPI
protein-binding annotation (partner ADSS2). Uninformative bare protein-binding evidence.
- id: Reactome:R-HSA-111524
title: IMP + L-Aspartate + GTP => Adenylosuccinate + GDP + Pi [ADSS]
findings:
- statement: Adenylosuccinate synthetase isoforms (including ADSSL1) catalyze the reaction
of IMP, aspartate, and GTP to form adenylosuccinate, GDP and orthophosphate in the
cytosol.
supporting_text: Two isoforms of adenylosuccinate synthetase, ADSS and ADSSL1, catalyze
the reaction of IMP, aspartate, and GTP to form adenylosuccinate, GDP, and
orthophosphate
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Reactome reaction for the adenylosuccinate synthase step; source of the
cytosol (TAS) localization. Title left exactly as fetched.
- id: file:human/ADSS1/ADSS1-uniprot.txt
title: UniProt entry Q8N142 (PURA1_HUMAN, ADSS1) - adenylosuccinate synthetase isozyme 1
findings:
- statement: ADSS1 catalyzes the Mg2+-dependent, GTP-dependent reaction of IMP with
L-aspartate to form adenylosuccinate, GDP and phosphate, the first committed step
(step 1 of 2) of the de novo AMP-from-IMP pathway; it is a cytoplasmic homodimer that
interacts with the paralog ADSS2.
supporting_text: N(6)-(1,2-dicarboxyethyl)-AMP + GDP
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Curated UniProt record; primary source for reaction, cofactor, pathway,
subcellular location, and the ADSS1-ADSS2 interaction used in this review.
suggested_questions:
- question: Does ADSS1 have non-catalytic or muscle-specific regulatory roles beyond the
purine nucleotide cycle that explain the tissue-restricted, distal-predominant myopathy
phenotype, given the ubiquitously expressed paralog ADSS2?
- question: Is the observed expression of AdSSL1 in stimulated leukemia/hematopoietic cells
associated with any genuine immune function, or purely a metabolic response?
suggested_experiments:
- description: Steady-state kinetic characterization of purified recombinant human ADSS1
(Km for IMP, L-aspartate, GTP; Mg2+ dependence) compared with ADSS2, to quantify the
muscle isozyme's catalytic properties.
hypothesis: The muscle isozyme ADSS1 has kinetic properties distinct from ADSS2 that suit
the high purine-nucleotide-cycle flux of skeletal muscle.
- description: Muscle-specific Adss1 knockout or knock-in of the MPD5 D304N variant in mouse
to test whether purine nucleotide cycle disruption drives the distal myopathy phenotype.
hypothesis: Loss of ADSS1 catalytic activity impairs the muscle purine nucleotide cycle,
causing the distal myopathy seen in MPD5 patients.